Navigation Links
24th Annual EAU Congress highlights many new developments
Date:2/5/2009

The 24th Annual Congress of the European Association of Urology (EAU) will be held from 17 to 21 March 2009 in the Stockholm International Fairs (SE). The EAU aims to present the best of scientific results, lectures and educational courses; the scientific programme covers the whole range of the urological field. Chairman of the EAU Scientific Congress Office Professor Freddie Hamdy has identified several scientific highlights.

In Stockholm the EAU expects to welcome an estimated 10,000 delegates and 3,000 exhibitors.

According to Professor Hamdy highlights include, among other things, the State-of-the-art lecture 'Watchful waiting versus radical prostatectomy - an updated from the SPCG-4 trial' by Professor Lars Holmberg from Uppsala (SE), held from 8:15 to 8:35 hours on Friday, 20 March. "In 2005 the researchers reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. Now results after 3 more years of follow-up are reported", he says.

The lecture 'The PCA3 test in the diagnosis of prostate cancer' by Dr. Monique Roobol from Rotterdam (NL) Friday 20 March from 9:20 to 9:35 hours gives an overview of the value of the Prostate Cancer Antigen 3 (PCA3) test for clinical applications based on the available literature and new data. The serum PSA value is the most commonly used marker in the detection and monitoring of prostate cancer, but prostate cancer is present throughout the entire PSA spectrum; this was confirmed by the biopsy results in men randomised to the control arm of the Prostate Cancer Prevention Trial (PCPT). Developments in molecular biology techniques have led to the identification of numerous genes and proteins that are believed to be relevant for the development of prostate cancer. This has resulted in a commercially available gene-based test, the PCA3 test.

On the same day, from 10:05 to 10:25 hours, Dr. Martin Gleave will give the Socit Internationale d'Urologie lecture 'Castration resistant prostate cancer: New therapeutic approaches'. Advanced prostate cancer has high initial response rates to androgen ablation. However, remissions are temporary because surviving tumour cells usually progress to castrate-refractory prostate cancer. Dr. Gleave will be discussing the status of several novel agents in clinical trials either as single agents or in combination with cytotoxic chemotherapy, including the androgen receptor, endothelin receptor, and molecular chaperones.

Dr. Smith from Boston (U.S.) is keen on presenting the exciting results of his trial (A randomized, double-blind, placebo-controlled trial of denosumab in men receiving androgen deprivation therapy for non-metastatic prostate cancer) from 10:25 to 10:55 hours as part of the 'The best EAU papers' session.

According to Dr. Johann de Bono from London (UK), who will be presenting 'New approaches to target androgen receptors in prostate cancer' from 11:45 to 12:00 hours, there is now incontrovertible evidence that what we have previously defined as hormone refractory prostate cancer is a disease that remains steroid hormone drive. Clinical evidence is now available that novel agents targeting androgen synthesis and more potent androgen receptor antagonists have significant antitumor activity. He will be reporting about trials with these novel agents.

On Saturday, 21 March, Professor Fritz Schrder from Rotterdam (NL) will be giving an important update on the European Randomised Study of Screening for Prostate Cancer (ERSPC) from 11:15 to 11:35 hours. The ERSPC is a large European study involving 8 countries (Belgium, Finland, France, Italy, Sweden, Spain, Switzerland and the Netherlands). This presentation will, for the first time, summarise results obtained by all centres.

More information about the new initiative 'EAU TV', the Meet-the-Expert sessions and the EAU Press Conference which will be opened by Swedish TV host and producer Mr Hasse Aro - will follow shortly.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
31-263-890-680
European Association of Urology
Source:Eurekalert

Related medicine news :

1. Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party
2. AUA Annual Scientific Meeting features more new research than ever before
3. Healthy Humor & Laughter are in the Cards at the 22nd Annual Association for Applied and Therapeutic Humor Conference
4. GBC Seeks Nominations for Fourth Annual Bioscience Awards
5. Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C.
6. Cadient Interactives Will Reese to Discuss Strategies for Engaging Physicians Online at Eighth Annual ePharma Summit
7. Align Technology Executives to Present at ROTH 21st Annual OC Growth Stock Conference
8. Elder Abuse Prevention the Focus of Wayne County Medical Society Foundations Annual Chinese New Year Fundraiser
9. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
10. Michigan Dentists Giving Free Dental Care to Low-Income Children During Annual Give Kids a Smile Program Starting February 6
11. Sunstar to Support ADAs 60th Annual National Childrens Dental Health Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology: